Tags : SmartPharm

Weekly Snapshot

Weekly Snapshot Jul 27- 31, 2020

 1.  Oxford Biomedica Signs Three Year Clinical Supply Agreement with Axovant to Manufacture and Supply AXO-Lenti-PD for Parkinson’s Disease  Published: Jul 31, 2020 | Tags: Oxford Biomedica, Signs, Three Year, Clinical Supply Agreement, Axovant, Manufacture, Supply, AXO-Lenti-PD, Parkinson’s Disease 2.  Johnson & Johnson Initiates P-I/IIa Study of its Ad26.COV2.S Against COVID-19 in the US and Belgium […]Read More

COVID-19 M&A

Sorrento to Acquire SmartPharm and Develop Pipeline of Gene-Encoded Therapeutic

Shots: Sorrento enters into letter of intent to acquire SmartPharm and develops pipeline of gene-encoded therapeutic Ab, initiating with Sorrento’s STI-1499 or COVI-GUARD, currently preclinical studies with an IND submission targeted for Aug’2020. The transaction is expected to be close in Aug’2020. The integration of Sorrento’s G-MAB Ab library and SmartPharm’s GET platform is expected […]Read More

Biotech COVID-19

Sorrento and SmartPharm To Develop Novel Gene-Encoded Antibody Vaccine for

Shots: The collaboration leverages Sorrento’s mAb against SARS-CoV-2 virus that will be encoded into a gene for delivery utilizing SmartPharm’s non-viral nanoparticle platform The companies are expected to develop a gene-encoded Abs that can be administered as prophylaxis against SARS-CoV-2 infection with the anticipated IND filing in the next few months SmartPharm’s Gene mAb platform […]Read More